WolfDYauCvan 't VeerL2021Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2-positive breast cancer in the adaptively randomized I-SPY2 trialNCBI Gene Expression OmnibusGSE181574. Here, ERBB2 is linked to breast cancer.